Literature DB >> 12093815

Noncatalytic domains of RGS9-1.Gbeta 5L play a decisive role in establishing its substrate specificity.

Kirill A Martemyanov1, Vadim Y Arshavsky.   

Abstract

The complex between the photoreceptor-specific regulator of G protein signaling (RGS) protein, RGS9-1, and type 5 G protein beta-subunit, Gbeta5L, regulates the duration of the cellular response to light by stimulating the GTPase activity of G protein, transducin. An important property of RGS9-1.Gbeta5L is that it interacts specifically with transducin bound to its effector, cGMP phosphodiesterase, rather than with transducin alone. The minimal structure within the RGS9-1.Gbeta5L complex capable of activating transducin GTPase is the catalytic domain of RGS9. This domain itself is also able to discriminate between free and effector-bound transducin but to a lesser degree than RGS9-1.Gbeta5L. The goal of this study was to determine whether other, noncatalytic domains of RGS9-1.Gbeta5L enhance the intrinsic specificity of the catalytic domain or whether they set the specificity of RGS9-1.Gbeta5L regardless of the specificity of its catalytic domain. We found that a double L353E/R360P amino acid substitution reversed the specificity of the recombinant catalytic domain but did not reverse the specificity of RGS9-1.Gbeta5L. However, the degree of discrimination between free and effector-bound transducin was reduced. Therefore, noncatalytic domains of RGS9-1.Gbeta5L play a decisive role in establishing its substrate specificity, yet the high degree of this specificity observed under physiological conditions requires an additional contribution from the catalytic domain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12093815     DOI: 10.1074/jbc.M205170200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Complementary interactions of the rod PDE6 inhibitory subunit with the catalytic subunits and transducin.

Authors:  Lian-Wang Guo; Abdol R Hajipour; Arnold E Ruoho
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

2.  Toward a unified model of vertebrate rod phototransduction.

Authors:  R D Hamer; S C Nicholas; D Tranchina; T D Lamb; J L P Jarvinen
Journal:  Vis Neurosci       Date:  2005 Jul-Aug       Impact factor: 3.241

Review 3.  The retinal cGMP phosphodiesterase gamma-subunit - a chameleon.

Authors:  Lian-Wang Guo; Arnold E Ruoho
Journal:  Curr Protein Pept Sci       Date:  2008-12       Impact factor: 3.272

Review 4.  Timing is everything: GTPase regulation in phototransduction.

Authors:  Vadim Y Arshavsky; Theodore G Wensel
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-21       Impact factor: 4.799

5.  N-terminal half of the cGMP phosphodiesterase gamma-subunit contributes to stabilization of the GTPase-accelerating protein complex.

Authors:  Lian-Wang Guo; Arnold E Ruoho
Journal:  J Biol Chem       Date:  2011-03-10       Impact factor: 5.157

6.  Palmitoylation and plasma membrane targeting of RGS7 are promoted by alpha o.

Authors:  Satoshi Takida; Christopher C Fischer; Philip B Wedegaertner
Journal:  Mol Pharmacol       Date:  2004-10-20       Impact factor: 4.436

7.  Multiple steps of phosphorylation of activated rhodopsin can account for the reproducibility of vertebrate rod single-photon responses.

Authors:  R D Hamer; S C Nicholas; D Tranchina; P A Liebman; T D Lamb
Journal:  J Gen Physiol       Date:  2003-09-15       Impact factor: 4.086

8.  Essential role for RGS9 in opiate action.

Authors:  Venetia Zachariou; Dan Georgescu; Nick Sanchez; Zia Rahman; Ralph DiLeone; Olivier Berton; Rachael L Neve; Laura J Sim-Selley; Dana E Selley; Stephen J Gold; Eric J Nestler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

Review 9.  Psychostimulants, madness, memory... and RGS proteins?

Authors:  Scott A Burchett
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 4.103

10.  Control of striatal signaling by g protein regulators.

Authors:  Keqiang Xie; Kirill A Martemyanov
Journal:  Front Neuroanat       Date:  2011-08-08       Impact factor: 3.856

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.